Supplementary Figure 5 from Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study
Autor: | Gooitzen M. van Dam, Vasilis Ntziachristos, Elisabeth G.E. de Vries, Paul J. van Diest, Elsken Van der Wall, Willem P.Th.M. Mali, Arjen J. Witkamp, Sabrina Oliveira, Sjoerd G. Elias, Wouter B. Nagengast, Bert van der Vegt, Esther de Boer, Matthijs D. Linssen, Annelies Jorritsma-Smit, Carolien P. Schröder, Marjolijn N. Lub-de Hooge, Jakob de Vries, Liesbeth Jansen, Anton G.T. Terwisscha van Scheltinga, Mariëtte E.G. Kranendonk, Jürgen Glatz, Arthur L.L. Adams, Johannes S. de Jong, Maximillian Koch, Laetitia E. Lamberts |
---|---|
Rok vydání: | 2023 |
Popis: | Co-localization of Bevacizumab-IRDye800CW, hematoxylin / eosin (H/E), VEGF-A, Collagen and CD34 in Ductal Carcinoma In Situ (DCIS). |
Databáze: | OpenAIRE |
Externí odkaz: |